Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry
Ken J Lu, Bryan P Yan, Andrew E Ajani, William M Wilson, Stephen J Duffy, Ronen Gurvitch, David J Clark, Angela Brennan, Christopher Reid, Nick Andrianopoulos, Henry Krum
European Journal of Heart Failure | OXFORD UNIV PRESS | Published : 2011
The Melbourne Interventional Group acknowledges unrestricted educational grant funding from Abbot Vascular, Astra-Zeneca, Biotronik, Boston-Scientific, Bristol-Myers Squibb, CSL, Johnson & Johnson, Medtronic, Pfizer, Schering-Plough, and Sanofi-Aventis & Servier. These companies do not have access to the data, and do not have the right to review manuscripts before publication. S.J.D. work is funded by a National Health and Medical Research Council of Australia Program Grant.